How unpopular is Swiss dental device company Nobel Biocare (OTCPK:NBHGY)? The stock was down 30% in 2012 and is down 75% over the past three years, but the stock still carries an overwhelming number of "Sell" recommendations. While Nobel has seen some significant negative developments in its core dental implants market, it's still worth asking whether this stock may not carry some value for risk-tolerant deep-value turnaround investors.
Focused On Better Smiles
While Nobel Biocare does offer a wide array of products including prosthetics like crowns and bridges and the NobelProcera CAD/CAM system, the business is very much built around its dental implants. As the name might suggest, dental implants are basically implantable products that are drilled/anchored into...
Only subscribers can access this article, which is part of the PRO research library covering 3,792 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: